Advanced control strategies for bioprocess chromatography: Challenges and opportunities for intensified processes and next generation products
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Recent advances in process analytical technologies and modelling techniques present opportunities to improve industrial chromatography control strategies to enhance process robustness, increase productivity and move towards real-time release testing. This paper provides a critical overview of batch and continuous industrial chromatography control systems for therapeutic protein purification. Firstly, the limitations of conventional industrial fractionation control strategies using in-line UV spectroscopy and on-line HPLC are outlined. Following this, an evaluation of monitoring and control techniques showing promise within research, process development and manufacturing is provided. These novel control strategies combine rapid in-line data capture (e.g. NIR, MALS and variable pathlength UV) with enhanced process understanding obtained from mechanistic and empirical modelling techniques. Finally, a summary of the future states of industrial chromatography control systems is proposed, including strategies to control buffer formulation, product fractionation, column switching and column fouling. The implementation of these control systems improves process capabilities to fulfil product quality criteria as processes are scaled, transferred and operated, thus fast tracking the delivery of new medicines to market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Wouters, O. J., McKee, M., & Luyten, J. (2020) · JAMA · doi:10.1001/jama.2020.1166 · Cited by 1,531
Biopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
Recent advances in (therapeutic protein) drug development
Lagassé, H. A. D., Alexaki, A., Simhadri, V. L., Katagiri, N. H., Jankowski, W., Sauna, Z. E., & Kimchi-Sarfaty, C. (2017) · F1000Research · doi:10.12688/f1000research.9970.1 · Cited by 481
Soft sensors in bioprocessing: A status report and recommendations
Luttmann, R., Bracewell, D. G., Cornelissen, G., Gernaey, K. V., Glassey, J., Hass, V. C., Kaiser, C., Preusse, C., Striedner, G., & Mandenius, C. (2012) · Biotechnology Journal · doi:10.1002/biot.201100506 · Cited by 238
Self-citationWasalathanthri, D. P., Rehmann, M. S., Song, Y., Gu, Y., Mi, L., Shao, C., Chemmalil, L., Lee, J., Ghose, S., Borys, M. C., et al. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27461 · Cited by 177
Rolinger, L., Rüdt, M., & Hubbuch, J. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02407-z · Cited by 126
Mini‐review: soft sensors as means for PAT in the manufacture of bio‐therapeutics
Mandenius, C., & Gustavsson, R. (2015) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.4477 · Cited by 84
Brennan, F. R., Cavagnaro, J., McKeever, K., Ryan, P. C., Schutten, M. M., Vahle, J., Weinbauer, G. F., Marrer-Berger, E., & Black, L. E. (2018) · mAbs · doi:10.1080/19420862.2017.1389364 · Cited by 70
Thakur, G., Hebbi, V., & Rathore, A. S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27236 · Cited by 64
Cited by
Bioprocess Control: Current Progress and Future Perspectives
Rathore, A. S., Mishra, S., Nikita, S., & Priyanka, P. (2021) · Life · doi:10.3390/life11060557 · Cited by 141
“Further, the MPC approach is considered as computationally expensive in comparison to other control strategies, especially when optimization is required at each time step [69,72].”
BackgroundCurrent PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
“They form the basis for real-time monitoring and can be integrated within a controller to enhance process control [113].”
Graf, T., Naumann, L., Bonnington, L., Heckel, J., Spensberger, B., Klein, S., Brey, C., Nachtigall, R., Mroz, M., Hogg, T. V., et al. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465013 · Cited by 24
Automated quality analysis in continuous downstream processes for small-scale applications
Tallvod, S., Espinoza, D., Gomis-Fons, J., Andersson, N., & Nilsson, B. (2023) · Journal of Chromatography A · doi:10.1016/j.chroma.2023.464085 · Cited by 11
Metadata
- Authors
- Armstrong, A., Horry, K., Cui, T., Hulley, M., Turner, R., Farid, S. S., Goldrick, S., & Bracewell, D. G.
- Venue
- Journal of Chromatography A
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 1639
- Pages
- 461914
- ISSN
- 0021-9673 (ISSN-L)
- OpenAlex
- W3120023607
- Cited by
- 40
- References
- 15
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced control strategies for bioprocess chromatography: Challenges and opportunities for intensified processes and next generation products. https://app.cochat.ai/papers/10.1016/j.chroma.2021.461914
- The paper
- Armstrong, A., Horry, K., Cui, T., Hulley, M., Turner, R., Farid, S. S., Goldrick, S., & Bracewell, D. G. (2021). Advanced control strategies for bioprocess chromatography: Challenges and opportunities for intensified processes and next generation products. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2021.461914
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.